... of health care," Burrill said. "That translates into investor interest." portfolio of 15 marketed treatments for HIV/AIDS, hepatitis, serious respiratory, cardiovascular, and metabolic conditions, cancer and inflammation, ranked ninth overall among ...
http://www.mercurynews.com/business/ci_23064559/sv-150-health-biomedical-industries-jump-value?source=rss
http://www.mercurynews.com/business/ci_23064559/sv-150-health-biomedical-industries-jump-value?source=rss
